Page 2090 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 123 The Blood Vessel Wall 1856.e3

110. Vittet D, Buchou T, Schweitzer A, et al: Targeted null-mutation in the 138. Shalaby F, Ho J, Stanford WL, et al: A requirement for Flk1 in primitive
vascular endothelial-cadherin gene impairs the organization of vascular- and definitive hematopoiesis and vasculogenesis. Cell 89:981, 1997.
like structures in embryoid bodies. Proc Natl Acad Sci USA 94:6273, 139. Fong GH, Rossant J, Gertsenstein M, et al: Role of the Flt-1 receptor
1997. tyrosine kinase in regulating the assembly of vascular endothelium.
111. Parise LV: JAM-1 regulation of endothelial cell migration: implications Nature 376:66, 1995.
for angiogenesis. Arterioscler Thromb Vasc Biol 23:2119, 2003. 140. Risau W: Mechanisms of angiogenesis. Nature 386:671, 1997.
112. Eichmann A, Le Noble F, Autiero M, et al: Guidance of vascular and 141. Davis S, Aldrich TH, Jones PF, et al: Isolation of angiopoietin-1, a
neural network formation. Curr Opin Neurobiol 15:108, 2005. ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell
113. Autiero M, De Smet F, Claes F, et al: Role of neural guidance signals 87:1161, 1996.
in blood vessel navigation. Cardiovasc Res 65:629, 2005. 142. Suri C, Jones PF, Patan S, et al: Requisite role of angiopoietin-1, a
114. Carmeliet P: Blood vessels and nerves: common signals, pathways and ligand for the TIE2 receptor, during embryonic angiogenesis. Cell
diseases. Nat Rev Genet 4:710, 2003. 87:1171, 1996.
115. Palmer TD: Adult neurogenesis and the vascular Nietzsche. Neuron 143. Maisonpierre PC, Suri C, Jones PF, et al: Angiopoietin-2, a natural
34:856, 2002. antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55,
116. Langille BL, O’Donnell F: Reductions in arterial diameter produced 1997.
by chronic decreases in blood flow are endothelium-dependent. Science 144. Ward NL, Dumont DJ: The angiopoietins and Tie2/Tek: adding to the
231:405, 1986. complexity of cardiovascular development. Semin Cell Dev Biol 13:19,
117. Harrison DG, Widder J, Grumbach I, et al: Endothelial mechanotrans- 2002.
duction, nitric oxide and vascular inflammation. J Intern Med 259:351, 145. Sato TN, Tozawa Y, Deutsch U, et al: Distinct roles of the receptor
2006. tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature
118. Lehoux S, Castier Y, Tedgui A: Molecular mechanisms of the 376:70, 1995.
vascular responses to haemodynamic forces. J Intern Med 259:381, 146. Vikkula M, Boon LM, Carraway KL, 3rd, et al: Vascular dysmorpho-
2006. genesis caused by an activating mutation in the receptor tyrosine kinase
119. Reneman RS, Arts T, Hoeks AP: Wall shear stress—an important TIE2. Cell 87:1181, 1996.
determinant of endothelial cell function and structure—in the arte- 147. Mustonen T, Alitalo K: Endothelial receptor tyrosine kinases involved
rial system in vivo. Discrepancies with theory. J Vasc Res 43:251, in angiogenesis. J Cell Biol 129:895, 1995.
2006. 148. Puri MC, Rossant J, Alitalo K, et al: The receptor tyrosine kinase TIE
120. Kaur B, Khwaja FW, Severson EA, et al: Hypoxia and the hypoxia- is required for integrity and survival of vascular endothelial cells. EMBO
inducible-factor pathway in glioma growth and angiogenesis. Neuro J 14:5884, 1995.
Oncol 7:134, 2005. 149. Partanen J, Puri MC, Schwartz L, et al: Cell autonomous functions
121. Arjamaa O, Nikinmaa M: Oxygen-dependent diseases in the retina: role of the receptor tyrosine kinase TIE in a late phase of angiogenic capil-
of hypoxia-inducible factors. Exp Eye Res 83:473, 2006. lary growth and endothelial cell survival during murine development.
122. Cho A, Courtman DW, Langille BL: Apoptosis (programmed cell Development 122:3013, 1996.
death) in arteries of the neonatal lamb. Circ Res 76:168, 1995. 150. Loughna S, Sato TN: A combinatorial role of angiopoietin-1 and
123. Desmouliere A, Redard M, Darby I, et al: Apoptosis mediates the orphan receptor TIE1 pathways in establishing vascular polarity during
decrease in cellularity during the transition between granulation tissue angiogenesis. Mol Cell 7:233, 2001.
and scar. Am J Pathol 146:56, 1995. 151. Alvarez RH, Kantarjian HM, Cortes JE: Biology of platelet-derived
124. Sakamaki K: Regulation of endothelial cell death and its role in angio- growth factor and its involvement in disease. Mayo Clin Proc 81:1241,
genesis and vascular regression. Curr Neurovasc Res 1:305, 2004. 2006.
125. Ferran C: Protective genes in the vessel wall: Modulators of graft 152. Leveen P, Pekny M, Gebre-Medhin S, et al: Mice deficient for PDGF
survival and function. Transplantation 82:S36, 2006. B show renal, cardiovascular, and hematological abnormalities. Genes
126. Beck L, Jr, D’Amore PA: Vascular development: cellular and molecular Dev 8:1875, 1994.
regulation. FASEB J 11:365, 1997. 153. Crosby JR, Tappan KA, Seifert RA, et al: Chimera analysis reveals
127. Risau W, Flamme I: Vasculogenesis. Annu Rev Cell Dev Biol 11:73, that fibroblasts and endothelial cells require platelet-derived growth
1995. factor receptor beta expression for participation in reactive connective
128. Bussolino F, Albini A, Camussi G, et al: Role of soluble mediators in tissue formation in adults but not during development. Am J Pathol
angiogenesis. Eur J Cancer 32A:2401, 1996. 154:1315, 1999.
129. Amaya E, Musci TJ, Kirschner MW: Expression of a dominant negative 154. Soriano P: Abnormal kidney development and hematological disorders
mutant of the FGF receptor disrupts mesoderm formation in Xenopus in PDGF beta-receptor mutant mice. Genes Dev 8:1888, 1994.
embryos. Cell 66:257, 1991. 155. Li X, Eriksson U: Novel PDGF family members: PDGF-C and PDGF-
130. Yamaguchi TP, Harpal K, Henkemeyer M, et al: Fgfr-1 is required for D. Cytokine Growth Factor Rev 14:91, 2003.
embryonic growth and mesodermal patterning during mouse gastrula- 156. Dickson MC, Martin JS, Cousins FM, et al: Defective haematopoiesis
tion. Genes Dev 8:3032, 1994. and vasculogenesis in transforming growth factor-beta 1 knock out
131. Presta M, Dell’Era P, Mitola S, et al: Fibroblast growth factor/fibroblast mice. Development 121:1845, 1995.
growth factor receptor system in angiogenesis. Cytokine Growth Factor 157. Oshima M, Oshima H, Taketo MM: TGF-beta receptor type II defi-
Rev 16:159, 2005. ciency results in defects of yolk sac hematopoiesis and vasculogenesis.
132. Olofsson B, Pajusola K, Kaipainen A, et al: Vascular endothelial growth Dev Biol 179:297, 1996.
factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci 158. Bertolino P, Deckers M, Lebrin F, et al: Transforming growth factor-
USA 93:2576, 1996. beta signal transduction in angiogenesis and vascular disorders. Chest
133. Jeltsch M, Kaipainen A, Joukov V, et al: Hyperplasia of lymphatic 128:585S, 2005.
vessels in VEGF-C transgenic mice. Science 276:1423, 1997. 159. Karsan A: The role of notch in modeling and maintaining the vascula-
134. Yamada Y, Nezu J, Shimane M, et al: Molecular cloning of a novel ture. Can J Physiol Pharmacol 83:14, 2005.
vascular endothelial growth factor, VEGF-D. Genomics 42:483, 160. Suchting S, Freitas C, le Noble F, et al: The Notch ligand Delta-like 4
1997. negatively regulates endothelial tip cell formation and vessel branching.
135. Klagsbrun M, Takashima S, Mamluk R: The role of neuropilin in Proc Natl Acad Sci USA 104:3225, 2007.
vascular and tumor biology. Adv Exp Med Biol 515:33, 2002. 161. Hellstrom M, Phng LK, Hofmann JJ, et al: Dll4 signalling through
136. Larrivee B, Karsan A: Signaling pathways induced by vascular endothe- Notch1 regulates formation of tip cells during angiogenesis. Nature
lial growth factor. Int J Mol Med 5:447, 2000. 445:776, 2007.
137. Patel-Hett S, D’Amore PA: Signal transduction in vasculogenesis and 162. Siekmann AF, Lawson ND: Notch signalling limits angiogenic cell
developmental angiogenesis. Int J Dev Biol 55:353, 2011. behaviour in developing zebrafish arteries. Nature 445:781, 2007.